HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chanel Foundation Launch Will Aim To Bridge Makeup, Skin Care

This article was originally published in The Rose Sheet

Executive Summary

Chanel Double Perfection Fluide Matte Reflecting Makeup SPF 15, a liquid companion to Double Perfection powder launching in January, is expected to build loyalty among Chanel's makeup customers and serve as a bridge to the company's Précision skin care collection, VP-Marketing Karen Flinn said

You may also be interested in...



Chanel Precision Trio Combats "First Signs" Of Aging In Younger Consumers

Chanel Skin Conscience Total Health moisturizers will be added to the Precision skin care line to target younger consumers who may have concerns about the "first signs" of aging, the company said at a press event in New York City Oct. 24. Aimed at consumers 35 and younger, the new cream, lotion and oil-free lotion will bow in May.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel